ObsEva (NASDAQ:OBSV) Earns Hold Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of ObsEva (NASDAQ:OBSV) in a research note issued to investors on Friday. The firm set a “hold” rating on the stock.

ObsEva Stock Down 100.0 %

ObsEva has a 12 month low of $0.08 and a 12 month high of $2.14. The company has a market capitalization of $7.94 million, a price-to-earnings ratio of -0.11 and a beta of 0.68.

About ObsEva

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.